Reuters logo
in 4 months
BRIEF-Aevi Genomic Medicine reports Q4 loss per share $0.23
March 9, 2017 / 1:55 PM / in 4 months

BRIEF-Aevi Genomic Medicine reports Q4 loss per share $0.23

1 Min Read

March 9 (Reuters) - Aevi Genomic Medicine Inc -

* Aevi Genomic Medicine reports fourth quarter and full year 2016 financial results and provides business update

* Q4 loss per share $0.23

* Q4 earnings per share view $-0.31 -- Thomson Reuters I/B/E/S

* Cash and cash equivalents as of December 31, 2016 were $39.84 million, compared to $53.06 million as of December 31, 2015

* Company expects its reported cash balance to fund operations through at least end of q1 2018

* Top-line data from saga phase 2/3 trial of AEVI-001 in adolescents with mGlur+ ADHD to be announced by end of q1 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below